/Sponsor / Executive Profile

Jonas Grossman

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $301M (29.9%)

Professional Biography

Jonas Grossman has been a prominent figure in the financial sector, serving as the Chief Executive Officer of our organization since June 2020. He is also a co-founder of the company and has played a significant role in its strategic direction and governance. In addition to his executive responsibilities, Mr. Grossman has been a member of our Board of Directors since July 2020. His extensive experience in capital markets is underscored by his long-standing position as Partner and Head of Capital Markets at Chardan Capital Markets LLC, a role he has held since December 2003. In this capacity, he oversees the firm’s global capital markets initiatives, including a focus on healthcare investment banking. Mr. Grossman’s leadership and expertise have been instrumental in driving our organization’s growth and success in the competitive financial landscape. His commitment to excellence and innovation continues to shape our strategic initiatives and operational effectiveness.

Total Capital Deployed

$1,007,500,000

Active / Searching Capital:
$301,000,000

Transaction Volume

8 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

25.0%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Robotics and Automation1 Deals
  • Battery Manufacturing1 Deals
  • Hospitality Technology1 Deals
  • biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
MTRY
Monterey Bio Acquisition Corporation
searching
101.0M
$10.00
1/1Sep 2021--GeneralChardan Capital Markets, LLC
CLAQ
CleanTech Acquisition Corp.
announced
250.0M
$10.00
1/2May 2021-
561.0M
Robotics and AutomationChardan Capital Markets, LLC
DFLI
Chardan NexTech Acquisition 2 Corp.
closed
100.0M
$10.00
1/3Mar 2021Done
415.0M
Battery ManufacturingChardan Capital Markets, LLC
CNAQ
Chardan NexTech Acquisition Corp.
searching
200.0M
$10.00
1/3Mar 2021--GeneralChardan Capital Markets, LLC
PRST
Ventoux CCM Acquisition Corp.
announced
151.5M
$8.21
1/2Dec 2020-
525.0M
Hospitality TechnologyChardan Capital Markets, LLC
RCOR
Chardan Healthcare Acquisition 2 Corp.
closed
85.0M
$10.00
1/2Mar 2020Done-GeneralChardan Capital Markets, LLC
LSAC
Vincerx Pharma, Inc.
announced
50.0M
$10.00
1/2Feb 2020-
55.0M
biopharmaceuticalChardan Capital Markets, LLC
PHGE
Chardan Healthcare Acquisition Corp.
announced
70.0M
$10.00
1/2Nov 2018--GeneralChardan Capital Markets, LLC